top of page
Anti-amyloid treatments slow the biological and clinical progression of Alzheimer’s disease.
Tue, 10 Nov
|Virtual event
Join us for a conversation with Dennis Selkoe on Alzheimer's disease risk and resilience, and how advances in genetics, neuroscience, and data science are helping us better understand the disease. Bring your questions!
Registration is closed


bottom of page